|
|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 14, Issue 1, 40-53, January 2003
and
§
§Instituto de Investigaciones
Biomédicas, CSIC, Madrid, Spain, and
The involvement of Rho GTPases in signal transduction
pathways leading to transcription activation is one of the major roles of this family of GTPases. Thus, the identification of transcription factors regulated by Rho GTPases and the understanding of the mechanisms of their activation and its biological outcome are of great
interest. Here, we provide evidence that Rho GTPases modulate Stat5a, a
transcription factor of the family of signal transducers and activators
of transcription. RhoA triggers tyrosine phosphorylation (Y696) of
Stat5a via a JAK2-dependent mechanism and promotes DNA-binding activity
of Stat5a. Tyrosine phosphorylation of Stat5a is also stimulated
physiologically by lysophosphatidic acid (LPA) in a
Rho-dependent manner. Simultaneously, RhoA reduces serine
phosphorylation of Stat5a at both serine residues S726 and S780,
resulting in a further increase of activity as defined by mutagenesis
experiments. Furthermore, serine dephosphorylation of Stat5a by RhoA
does not take place by down-modulation of either JNK1, MEK1, or p38 MAP
kinases, as determined by transfection experiments or chemical
inhibition of both MEK1, p38, and JNK serine kinases. Thus, RhoA
regulates Stat5a via tyrosine phosphorylation and via a yet to be
determined novel down-modulating pathway that involves serine
dephosphorylation. Finally, we provide evidence for a role of Stat5a in
RhoA-induced epithelial-to-mesenchymal transition with concomitant
increase in vimentin expression, E-cadherin down-regulation, and cell motility.
Department of Pathology, Uniformed Services
University of the Health Sciences, Bethesda, Maryland 20829
Corresponding author. E-mail address:
jclacal{at}iib.uam.es.
This article has been cited by other articles:
![]() |
V. Kundumani-Sridharan, D. Wang, M. Karpurapu, Z. Liu, C. Zhang, N. Dronadula, and G. N. Rao Suppression of Activation of Signal Transducer and Activator of Transcription-5B Signaling in the Vessel Wall Reduces Balloon Injury-Induced Neointima Formation Am. J. Pathol., October 1, 2007; 171(4): 1381 - 1394. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Lee, K. Man, R. T.P. Poon, C. M. Lo, A. P. Yuen, I. O. Ng, K. T. Ng, W. Leonard, and S. T. Fan Signal Transducers and Activators of Transcription 5b Activation Enhances Hepatocellular Carcinoma Aggressiveness through Induction of Epithelial-Mesenchymal Transition. Cancer Res., October 15, 2006; 66(20): 9948 - 9956. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Akhtar and C. H. Streuli Rac1 links integrin-mediated adhesion to the control of lactational differentiation in mammary epithelia J. Cell Biol., June 5, 2006; 173(5): 781 - 793. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Woods, G. Wang, and F. Beier RhoA/ROCK Signaling Regulates Sox9 Expression and Actin Organization during Chondrogenesis J. Biol. Chem., March 25, 2005; 280(12): 11626 - 11634. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. V. Clevenger Roles and Regulation of Stat Family Transcription Factors in Human Breast Cancer Am. J. Pathol., November 1, 2004; 165(5): 1449 - 1460. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ling and P. E. Lobie RhoA/ROCK Activation by Growth Hormone Abrogates p300/Histone Deacetylase 6 Repression of Stat5-mediated Transcription J. Biol. Chem., July 30, 2004; 279(31): 32737 - 32750. [Abstract] [Full Text] [PDF] |
||||